No credit card. No commitment.
5000+ G2 reviews
LexaGene
Research
Public company
Founded in 2016
Beverly, MassachusettsLexaGene
ResearchPublic companyFounded in 2016Beverly, Massachusetts
EmployeesLexaGene's financial review
LexaGene's Revenue (Yearly)
167K
Employees
8
Total Funding
23.2M
Last Funding Round
1.6M
tsx
LXG
LexaGene information
LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a molecular diagnostics company developing an open-access, fully automated system for rapid and sensitive pathogen detection. Our MiQLab® System is PCR-based instrument that can detect up to 27 targets at once for testing in human clinical and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical an...
LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a molecular diagnostics company developing an open-access, fully automated system for rapid and sensitive pathogen detection. Our MiQLab® System is PCR-based instrument that can detect up to 27 targets at once for testing in human clinical and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.
LexaGene industries
Molecular diagnostics
Veterinary diagnostics
Human clinical diagnostics
Openaccess testing
LexaGene's financial review
LexaGene's Revenue (Yearly)
167K
Employees
8
Total Funding
23.2M
Last Funding Round
1.6M
tsx
LXG
Employee Metrics
Technologies
Email Delivery
Email Delivery
Email Providers
Other
Hosting
Notable Alumni
Employees
Controller
CTO, Founder
Scientist
Operations Administrator LexaGene
Sales Manager
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
